Page 2 - Brca 2 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The risk factor groups are the ones that they may have genetic family history of ovarian cancer and if you have one of these genes, brca-1 and brca-2, they are at high risk and if you have never been pregnant in the past, it is a risk, and, obesity is a risk and, the exciting thing about ovarian cancer, there is a group in yale, coming up with a genetic testing or screening and i'm excited about this, because they are looking at a few proteins that change in our dna when it comes to ovarian cancer, such as prolactin, or insulin growth factors, or lecthin and that is 20 to $30 for the test and ...

Are these producing something the public benefits from? when it comes to some that have been used to inspire therapeutic development, they would say they've not really invested hundreds of millions of drollar if they had not had a patent on the gene. they were afraid somebody else would sweep in take over their market after they did all the work. perhaps they have benefitted the public. in diagnostics, on the other hand. like the brca1, and the brca 2 patent, there's a much better argument on whether it's gotten in the way of competition and improving the cost curve. costs are still pretty hig...

Latest updates on this topic from reliable sources.